What Can Diagnostics Founders Learn From Two Successful Exits? Andrew Miller
In this episode of Diagnosing Dx, David Filby is joined by Andrew Miller, a diagnostics founder, advisor and two-time exited CEO.
A scientist by training, Andrew founded and led companies focused on rapid molecular diagnostics, taking Ionian Technologies through acquisition by Alere and later building NAT Diagnostics, which was acquired by Becton Dickinson in 2020. The technology developed at Ionian ultimately became central to Abbott’s ID NOW platform.
Andrew shares what he learned from going through the acquisition process twice, why his second company was designed for sale from the outset…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.